These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29262697)

  • 41. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
    Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
    Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of open-access vancomycin dosing websites.
    Fewel NP
    J Clin Pharm Ther; 2017 Apr; 42(2):128-131. PubMed ID: 27757973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
    Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
    Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of variables for potential impact on vancomycin pharmacokinetics in thermal or inhalation injury.
    Elder K; Hill DM; Hickerson WL
    Burns; 2018 May; 44(3):658-664. PubMed ID: 29097070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients.
    Kassel LE; Van Matre ET; Foster CJ; Fish DN; Mueller SW; Sherman DS; Wempe MF; MacLaren R; Neumann RT; Kiser TH
    Pharmacotherapy; 2018 Sep; 38(9):921-934. PubMed ID: 29906310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals.
    Smit C; Wasmann RE; Goulooze SC; Wiezer MJ; van Dongen EPA; Mouton JW; Brüggemann RJM; Knibbe CAJ
    Br J Clin Pharmacol; 2020 Feb; 86(2):303-317. PubMed ID: 31661553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
    Thomas CA; Picone A; Menon S; Willis BC
    Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice.
    Elbarbry F
    Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):259-268. PubMed ID: 29260505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vancomycin Dosing in Children With Overweight or Obesity: A Systematic Review and Meta-analysis.
    Khare M; Azim A; Kneese G; Haag M; Weinstein K; Rhee KE; Foster BA
    Hosp Pediatr; 2020 Apr; 10(4):359-368. PubMed ID: 32213528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.
    Morbitzer KA; Jordan JD; Sullivan KA; Durr EA; Olm-Shipman CM; Rhoney DH
    Neurocrit Care; 2016 Oct; 25(2):250-7. PubMed ID: 26942732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years.
    Grace E
    J Antimicrob Chemother; 2012 Jun; 67(6):1305-10. PubMed ID: 22382471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum Creatinine.
    Young T; Daniel M; Baumhover S; Eidson D; Green J
    Drugs R D; 2017 Sep; 17(3):435-440. PubMed ID: 28815425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
    Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.